000 | 01953 a2200601 4500 | ||
---|---|---|---|
005 | 20250515152811.0 | ||
264 | 0 | _c20090204 | |
008 | 200902s 0 0 eng d | ||
022 | _a1527-3792 | ||
024 | 7 |
_a10.1016/j.juro.2008.10.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThomas, Anil A | |
245 | 0 | 0 |
_aResponse of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. _h[electronic resource] |
260 |
_bThe Journal of urology _cFeb 2009 |
||
300 |
_a518-23; discussion 523 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aBiopsy, Needle |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aIndoles _xadministration & dosage |
650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoadjuvant Therapy _xmethods |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNephrectomy _xmethods |
650 | 0 | 4 |
_aPreoperative Care _xmethods |
650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSunitinib |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aRini, Brian I | |
700 | 1 | _aLane, Brian R | |
700 | 1 | _aGarcia, Jorge | |
700 | 1 | _aDreicer, Robert | |
700 | 1 | _aKlein, Eric A | |
700 | 1 | _aNovick, Andrew C | |
700 | 1 | _aCampbell, Steven C | |
773 | 0 |
_tThe Journal of urology _gvol. 181 _gno. 2 _gp. 518-23; discussion 523 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.juro.2008.10.001 _zAvailable from publisher's website |
999 |
_c18551426 _d18551426 |